Results 121 to 130 of about 17,480 (219)

Infliximab in Takayasu arteritis: a safe alternative?

open access: yes, 2007
Objective: To test the efficacy of Infliximab, a chimeric monoclonal antibody against TNF-alpha, in the treatment of Takayasu arteritis. Materials and methods: We used infliximab at an initial dose of 3 mg/kg i.v.
Skopouli, Fotini N.   +4 more
core   +1 more source

TAKAYASU ARTERITIS AND RENAL AUTO TRANSPLANTATION IN CHILDHOOD

open access: yesTurkish Journal of Nephrology, 2019
Takayasu arteritis is a vasculitis of aorta and large vessels and it is rarely diagnosed in childhood in Turkey. An 11-year old girl was admitted for the manifestations of hypertensive cardiomyopathy and congestive heart failure. As plasma renin activity
Ayşe ÖNER   +7 more
doaj  

Neurological Complications in Pediatric Takayasu Arteritis: Insights from a Single-Center Experience. [PDF]

open access: yesJ Clin Med
Sengenc E   +9 more
europepmc   +1 more source

Anti endothelial cell antibodies in Takayasu arteritis

open access: yes, 1996
BACKGROUND: Although a specific etiology for Takayasu arteritis has not been found, the bulk of evidence favors an autoimmune mechanism. We examined the sera of 19 patients with Takayasu arteritis for antineutrophil cytoplasmic antibodies (ANCA ...
Turowski, A.   +8 more
core  

Insidious: Takayasu Arteritis [PDF]

open access: yesThe American Journal of Medicine, 2015
Fátima, Rodriguez   +4 more
openaire   +2 more sources

Atypical Takayasu arteritis: A family with five affected siblings

open access: yes, 2007
Background: Takayasu disease is a giant cell arteritis, primarily affecting the aorta and its main branches, particularly over the first 1.5 cm. It is more common in South-East Asian countries and in young females, whose clinical manifestations range ...
Jeeva, Irfan   +4 more
core  

Aortitis as a High-Risk Vascular Syndrome: Integrating Phenotype-Driven Diagnosis, Multidisciplinary Assessment, and Personalised Management. [PDF]

open access: yesJ Pers Med
Georghiou GP   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy